GCA
ALXN
Gideon Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,734
| Closed | -$1.92M | – | 236 |
|
|
2019
Q4 | $1.92M | Buy |
17,734
+10,092
| +132% | +$1.09M | 0.66% | 51 |
|
|
2019
Q3 | $748K | Buy |
7,642
+352
| +5% | +$34.5K | 0.24% | 139 |
|
|
2019
Q2 | $955K | Buy |
+7,290
| New | +$955K | 0.33% | 117 |
|
|
2019
Q1 | – | Sell |
-8,358
| Closed | -$814K | – | 554 |
|
|
2018
Q4 | $814K | Buy |
+8,358
| New | +$814K | 0.33% | 89 |
|
|
2018
Q3 | – | Sell |
-2,472
| Closed | -$307K | – | 526 |
|
|
2018
Q2 | $307K | Buy |
+2,472
| New | +$307K | 0.15% | 252 |
|
|
2017
Q4 | – | Sell |
-4,471
| Closed | -$627K | – | 439 |
|
|
2017
Q3 | $627K | Buy |
4,471
+807
| +22% | +$113K | 0.62% | 24 |
|
|
2017
Q2 | $446K | Buy |
3,664
+1,511
| +70% | +$184K | 0.49% | 62 |
|
|
2017
Q1 | $261K | Buy |
+2,153
| New | +$261K | 0.16% | 297 |
|
|
2015
Q2 | – | Sell |
-1,166
| Closed | -$202K | – | 333 |
|
|
2015
Q1 | $202K | Buy |
+1,166
| New | +$202K | 0.08% | 210 |
|
|
2014
Q3 | – | Sell |
-10,098
| Closed | -$1.58M | – | 381 |
|
|
2014
Q2 | $1.58M | Buy |
+10,098
| New | +$1.58M | 0.57% | 58 |
|